文献速递临床试验与 GCP

芝麻油与葵花籽油对非酒精性脂肪肝女性血脂、血压及人体测量指标影响的随机双盲对照试验

The effect of sesame oil consumption compared to sunflower oil on lipid profile, blood pressure, and anthropometric indices in women with non-alcoholic fatty liver disease: a randomized double-blind controlled trial.
PubMed 文献 · Trials · 2022-07-08

本随机双盲对照试验纳入60名非酒精性脂肪肝女性,随机分为芝麻油组(n=30)和葵花籽油组(n=30),每日各摄入30克油并配合低热量饮食(-500 kcal/天)12周。53人完成研究后,两组人体测量指标和收缩压均显著下降,芝麻油组舒张压显著下降;两组血脂谱无显著变化,校正混杂因素后芝麻油组舒张压和总胆固醇/高密度脂蛋白胆固醇比值较葵花籽油组显著降低。

要点

  • 芝麻油与葵花籽油对非酒精性脂肪肝女性的人体测量指标、收缩压和血脂谱影响无显著差异(总胆固醇/高密度脂蛋白胆固醇比值除外)。
  • 芝麻油可能较葵花籽油更有效改善舒张压和总胆固醇/高密度脂蛋白胆固醇比值。
  • 两组均配合低热量饮食(-500 kcal/天),干预12周。

核心结论

  • 芝麻油和葵花籽油可能对人体测量指标、收缩压和血脂谱的影响无差异,但总胆固醇/高密度脂蛋白胆固醇比值除外。
  • 芝麻油可能较葵花籽油组更有效改善舒张压和总胆固醇/高密度脂蛋白胆固醇比值。

研究设计与样本

  • 随机双盲对照试验,纳入60名非酒精性脂肪肝女性,随机分为芝麻油组(n=30)和葵花籽油组(n=30)。
  • 每人每日摄入30克油,持续12周,所有参与者接受低热量饮食(-500 kcal/天)。
  • 在干预前后评估血脂谱、血压和人体测量指标。

主要发现

  • 共53名参与者完成研究。
  • 干预12周后,两组人体测量指标(p < 0.001)和收缩压(p < 0.05)均显著降低,芝麻油组舒张压显著降低(p = 0.03)。
  • 两组血脂谱均无显著变化(p > 0.05)。
  • 校正混杂因素后,芝麻油组舒张压(p = 0.031)和总胆固醇/高密度脂蛋白胆固醇比值(p = 0.039)较葵花籽油组显著降低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in the world. There is strong evidence that dyslipidemia and other cardio-metabolic disorders are highly prevalent in patients with NAFLD. This trial aimed at examining the effect of sesame oil (SO) in the context of a weight loss program on lipid profile, blood pressure, and anthropometric indices in women with NAFLD. METHODS: This randomized, double-blind, controlled trial was carried out on 60 women with NAFLD. Subjects were randomly assigned to the SO group (n = 30) and sunflower oil (SFO) group (n = 30), each person consuming 30 g of oil per day for 12 weeks. All the participants received a hypocaloric diet (- 500 kcal/day) during the study. Lipid profile, blood pressure, and anthropometric indices were assessed at pre- and post-intervention phases. RESULTS: In total, 53 participants completed the study. Following 12 weeks of intervention, anthropometric indices (p < 0.001) and systolic blood pressure (SBP) (p < 0.05) were significantly decreased in both groups and diastolic blood pressure (DBP) was significantly decreased in So group (p = 0.03). There was no significant change in lipid profile in both groups (p > 0.05). After adjusting for confounders, DBP (p = 0.031) and total cholesterol (TC) divided by high-density lipoprotein cholesterol (HDL-C) (p = 0.039) in the SO group were significantly reduced compared to the SFO group (p < 0.05). CONCLUSIONS: The present clinical trial revealed that SO and SFO may not differently affect anthropometric indices, SBP, and lipid profile except for TC/HDL-C. In addition, SO may be effective in improvement of DBP and TC/HDL-C compared to the SFO group. TRIAL REGISTRATION: Ethical approval of this trial was obtained at Isfahan University of Medical Sciences with the reference number of IR.MUI. RESEARCH: REC.1399.548 ( https://ethics. RESEARCH: ac.ir/ProposalCertificateEn.php?id=158942&Print=true&NoPrintHeader=true&NoPrintFooter=true&NoPrintPageBorder=true&LetterPrint=true ), and it was registered before the start of the patient recruitment on December 12th, 2020 in the Iranian Registry of Clinical Trials (IRCT) with the registration number of IRCT20140208016529N6 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Vahedi H, Atefi M, Entezari MH, et al. The effect of sesame oil consumption compared to sunflower oil on lipid profile, blood pressure, and anthropometric indices in women with non-alcoholic fatty liver disease: a randomized double-blind controlled trial. Trials. 2022. PMID: 35804451. doi:10.1186/s13063-022-06451-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。